Metraipolis › archive › dc_1d3f2a0dd910
Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer — Europe PMC PMID:41589227
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41589227
- DOI
- 10.1007/s13691-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T11:00:42.329Z
- SHA-256 of the archived text
b592ed7a435de47b9029bbe70249b35bac6288f65bda4c2d6067d8028ae0cbb7- Stable URL of this page
https://metraipolis.com/documento/dc_1d3f2a0dd910
How to cite
Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer — Europe PMC PMID:41589227 — Europe PMC (en), https://europepmc.org/article/MED/41589227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1d3f2a0dd910 (Metraipolis archive dc_1d3f2a0dd910, sha256 b592ed7a435de47b9029bbe70249b35bac6288f65bda4c2d6067d8028ae0cbb7)
BibTeX
@misc{dc1d3f2a0dd910,
title = {Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer — Europe PMC PMID:41589227},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41589227},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1d3f2a0dd910; sha256 b592ed7a435de47b9029bbe70249b35bac6288f65bda4c2d6067d8028ae0cbb7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41589227. Agents can read the archived copy with the MCP tool read_document.